Figure 4.
Effect of SRT2104 on markers of platelet and monocyte activation. Data presented as mean±SD. PMA indicates platelet–monocyte aggregate; Mac‐1, macrophage‐1 antigen; sCD40L, soluble CD40 ligand.
Effect of SRT2104 on markers of platelet and monocyte activation. Data presented as mean±SD. PMA indicates platelet–monocyte aggregate; Mac‐1, macrophage‐1 antigen; sCD40L, soluble CD40 ligand.